These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance. Br J Haematol; 1973 Jan; 24(1):123-39. PubMed ID: 4805842 [No Abstract] [Full Text] [Related]
6. Normal immunoglobulins in multiple myeloma: effect of melphalan chemotherapy. Alexanian R; Migliore PJ J Lab Clin Med; 1970 Feb; 75(2):225-33. PubMed ID: 5414404 [No Abstract] [Full Text] [Related]
7. Treatment of plasma cell myeloma with cytotoxic agents. Bergsagel DE; Pruzanski W Arch Intern Med; 1975 Jan; 135(1):172-6. PubMed ID: 803363 [TBL] [Abstract][Full Text] [Related]
8. [Hypolipidemia in myeloma]. Fiessinger JN; Ollier MP; Filitti-Wurmser S; Hartmann L Ann Biol Clin (Paris); 1971; 29(1):25-37. PubMed ID: 4996178 [No Abstract] [Full Text] [Related]
9. Hypoalbuminemia in patients with multiple myeloma. Chen YH; Magalhaes MC Arch Intern Med; 1990 Mar; 150(3):605-10. PubMed ID: 2310279 [TBL] [Abstract][Full Text] [Related]
10. Prognostic factors and the effect of alkylating agents on survival in multiple myeloma. A review of 80 patients. Matzner Y; Benbassat J; Polliack A Isr J Med Sci; 1977 Aug; 13(8):797-807. PubMed ID: 408296 [No Abstract] [Full Text] [Related]
12. IV. Detection and differentiation of M-proteins by the acid-gel reaction--a re-evaluation. Daniels JC; Cobb EK; Levin WC; Ritzmann SE Tex Rep Biol Med; 1970; 28(4):541-5. PubMed ID: 4995465 [No Abstract] [Full Text] [Related]
13. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria. Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741 [TBL] [Abstract][Full Text] [Related]
14. [2 new cases of initial or secondarily non-excreting plasma cell myelomas]. Prost A; Soulilou JP; Gardais J; Hurez D; Cottin S Rev Rhum Mal Osteoartic; 1973 Feb; 40(2):151-7. PubMed ID: 4574504 [No Abstract] [Full Text] [Related]
15. Multiple myeloma without initial paraproteins. Kim I; Harley JB; Weksler B Am J Med Sci; 1972 Oct; 264(4):267-75. PubMed ID: 4630526 [No Abstract] [Full Text] [Related]
17. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults. Buckman R; Cuzick J; Galton DA Br J Haematol; 1982 Dec; 52(4):589-99. PubMed ID: 6958312 [TBL] [Abstract][Full Text] [Related]
18. Gel filtration analysis of multiple myeloma sera. Tóth I; Sellei C; Eckhardt S; Hindy I Haematologia (Budap); 1973; 7(1):7-16. PubMed ID: 4737470 [No Abstract] [Full Text] [Related]
19. [Prognosis in myelomatosis treated with prednisone and cytostatics]. Hansen OP; Jessen B; Videbaek A Ugeskr Laeger; 1973 Jun; 135(23):1169-73. PubMed ID: 4757116 [No Abstract] [Full Text] [Related]